Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Hypertension potential efficacy biomarker for metastatic renal cell carcinoma - HemOncToday |
 |
 |
|
HemOncToday Patients who developed sunitinib-associated hypertension while being treated for metastatic renal cell carcinoma lived more than 30 months longer than patients with normal blood pressure, according to the results of a recently published study. |
